|
1
|
Ellis JM, Frahm JL, Li LO and Coleman RA:
Acyl-coenzyme A synthetases in metabolic control. Curr Opin
Lipidol. 21:212–217. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Grevengoed TJ, Klett EL and Coleman RA:
Acyl-CoA metabolism and partitioning. Annu Rev Nutr. 34:1–30. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Neess D, Bek S, Engelsby H, Gallego SF and
Færgeman NJ: Long-chain acyl-CoA esters in metabolism and
signaling: Role of acyl-CoA binding proteins. Prog Lipid Res.
59:1–25. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Digel M, Ehehalt R, Stremmel W and
Füllekrug J: Acyl-CoA synthetases: Fatty acid uptake and metabolic
channeling. Mol Cell Biochem. 326:23–28. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fujimoto Y, Itabe H, Kinoshita T, Homma
KJ, Onoduka J, Mori M, Yamaguchi S, Makita M, Higashi Y, Yamashita
A and Takano T: Involvement of ACSL in local synthesis of neutral
lipids in cytoplasmic lipid droplets in human hepatocyte HuH7. J
Lipid Res. 48:1280–1292. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li LO, Ellis JM, Paich HA, Wang S, Gong N,
Altshuller G, Thresher RJ, Koves TR, Watkins SM, Muoio DM, et al:
Liver-specific loss of long chain acyl-CoA synthetase-1 decreases
triacylglycerol synthesis and beta-oxidation and alters
phospholipid fatty acid composition. J Biol Chem. 284:27816–27826.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ellis JM, Li LO, Wu PC, Koves TR, Ilkayeva
O, Stevens RD, Watkins SM, Muoio DM and Coleman RA: Adipose
acyl-CoA synthetase-1 directs fatty acids toward beta-oxidation and
is required for cold thermogenesis. Cell Metab. 12:53–64. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li LO, Grevengoed TJ, Paul DS, Ilkayeva O,
Koves TR, Pascual F, Newgard CB, Muoio DM and Coleman RA:
Compartmentalized acyl-CoA metabolism in skeletal muscle regulates
systemic glucose homeostasis. Diabetes. 64:23–35. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ellis JM, Mentock SM, Depetrillo MA, Koves
TR, Sen S, Watkins SM, Muoio DM, Cline GW, Taegtmeyer H, Shulman
GI, et al: Mouse cardiac acyl coenzyme a synthetase 1 deficiency
impairs Fatty Acid oxidation and induces cardiac hypertrophy. Mol
Cell Biol. 31:1252–1262. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bowman TA, O'Keeffe KR, D'Aquila T, Yan
QW, Griffin JD, Killion EA, Salter DM, Mashek DG, Buhman KK and
Greenberg AS: Acyl CoA synthetase 5 (ACSL5) ablation in mice
increases energy expenditure and insulin sensitivity and delays fat
absorption. Mol Metab. 5:210–220. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sanchez-Martinez R, Cruz-Gil S,
García-Álvarez MS, Reglero G and Ramirez de Molina A: Complementary
ACSL isoforms contribute to a non-Warburg advantageous energetic
status characterizing invasive colon cancer cells. Sci Rep.
7:111432017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sánchez-Martínez R, Cruz-Gil S, Gómez de
Cedrón M, Álvarez-Fernández M, Vargas T, Molina S, García B,
Herranz J, Moreno-Rubio J, Reglero G, et al: A link between lipid
metabolism and epithelial-mesenchymal transition provides a target
for colon cancer therapy. Oncotarget. 6:38719–38736. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Y, Cai X, Zhang S, Cui M, Liu FSun B,
Zhan W, Zhang X and Ye L: HBXIP up-regulates ACSL1 through
activating transcriptional factor Sp1 in breast cancer. Biochem
Biophys Res Commun. 484:565–571. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cui M, Wang Y, Sun B, Xiao Z, Ye L and
Zhang X: MiR-205 modulates abnormal lipid metabolism of hepatoma
cells via targeting acyl-CoA synthetase long-chain family member 1
(ACSL1) mRNA. Biochem Biophys Res Commun. 444:270–275. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cui M, Xiao Z, Wang Y, Zheng M, Song T,
Cai X, Sun B, Ye L and Zhang X: Long noncoding RNA HULC modulates
abnormal lipid metabolism in hepatoma cells through an
miR-9-mediated RXRA signaling pathway. Cancer research. 75:846–857.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ivyna Bong PN, Ng CC, Lam KY, Megat
Baharuddin PJ, Chang KM and Zakaria Z: Identification of novel
pathogenic copy number aberrations in multiple myeloma: The
Malaysian. Mol Cytogenet. 7:242014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang W, Jin Y, Yuan Y, Bai C, Wu Y2, Zhu
H and Lu S: Validation and target gene screening of hsa-miR-205 in
lung squamous cell carcinoma. Chin Med J (Engl). 127:272–278.
2014.PubMed/NCBI
|
|
18
|
Vargas T, Moreno-Rubio J, Herranz J, Cejas
P, Molina S, Mendiola M, Burgos E, Custodio AB, de Miguel M, et al:
3′ UTR polymorphism in ACSL1 gene correlates with expression levels
and poor clinical outcome in colon cancer patients. PLoS One.
11:e01684232016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cao Y, Dave KB, Doan TP and Prescott SM:
Fatty acid CoA ligase 4 is up-regulated in colon adenocarcinoma.
Cancer Res. 61:8429–8434. 2001.PubMed/NCBI
|
|
20
|
Wu X, Li Y, Wang J, Wen X, Marcus MT,
Daniels G, Zhang DY, Ye F, Wang LH, Du X, et al: Long chain fatty
acyl-CoA synthetase 4 is a biomarker for and mediator of hormone
resistance in human breast cancer. PloS one. 8:e770602013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xia H, Lee KW, Chen J, Kong SN, Sekar K,
Deivasigamani A, Seshachalam VP, Goh BKP, Ooi LL, Hui KM, et al:
Simultaneous silencing of ACSL4 and induction of GADD45B in
hepatocellular carcinoma cells amplifies the synergistic
therapeutic effect of aspirin and sorafenib. Cell Death Discov.
3:170582017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sung YK, Hwang SY, Park MK, Bae HI, Kim
WH, Kim JC and Kim M: Fatty acid-CoA ligase 4 is overexpressed in
human hepatocellular carcinoma. Cancer Sci. 94:421–424. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hu C, Chen L, Jiang Y, Li Y and Wang S:
The effect of fatty acid-CoA ligase 4 on the growth of hepatic
cancer cells. Cancer Biol Ther. 7:131–134. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu X, Deng F, Li Y, Daniels G, Du X, Ren
Q, Wang J, Wang LH, Yang Y, Zhang V, et al: ACSL4 promotes prostate
cancer growth, invasion and hormonal resistance. Oncotarget.
6:44849–44863. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ye X, Zhang Y, Wang X, Li Y and Gao Y:
Tumor-suppressive functions of long-chain acyl-CoA synthetase 4 in
gastric cancer. IUBMB Life. 68:320–327. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gassler N, Schneider A, Kopitz J,
Schnölzer M, Obermüller N, Kartenbeck J, Otto HF and Autschbach F:
Impaired expression of acyl-CoA-synthetase 5 in epithelial tumors
of the small intestine. Hum Pathol. 34:1048–1052. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yen MC, Kan JY, Hsieh CJ, Kuo PL, Hou MF
and Hsu YL: Association of long-chain acyl-coenzyme A synthetase 5
expression in human breast cancer by estrogen receptor status and
its clinical significance. Oncol Rep. 37:3253–3260. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gaisa NT, Reinartz A, Schneider U, Klaus
C, Heidenreich A, Jakse G, Kaemmerer E, Klinkhammer BM, Knuechel R
and Gassler N: Levels of acyl-coenzyme A synthetase 5 in urothelial
cells and corresponding neoplasias reflect cellular
differentiation. Histol Histopathol. 28:353–364. 2013.PubMed/NCBI
|
|
29
|
Yamashita Y, Kumabe T, Cho YY, Watanabe M,
Kawagishi J, Yoshimoto T, Fujino T, Kang MJ and Yamamoto TT: Fatty
acid induced glioma cell growth is mediated by the acyl-CoA
synthetase 5 gene located on chromosome 10q25.1-q25.2, a region
frequently deleted in malignant gliomas. Oncogene. 19:5919–5925.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim SY, Ahn T, Bang H, Ham JS, Kim J, Kim
ST, Jang J, Shim M, Kang SY, Park SH, et al: Acquired resistance to
LY2874455 in FGFR2-amplified gastric cancer through an emergence of
novel FGFR2-ACSL5 fusion. Oncotarget. 8:15014–15022.
2017.PubMed/NCBI
|
|
31
|
Padanad MS, Konstantinidou G,
Venkateswaran N, Melegari M, Rindhe S, Mitsche M, Yang C, Batten K,
Huffman KE, Liu J, et al: Fatty acid oxidation mediated by acyl-CoA
synthetase long Chain 3 is required for mutant KRAS lung
tumorigenesis. Cell Rep. 16:1614–1628. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Obinata D, Takayama K, Fujiwara K, Suzuki
T, Tsutsumi S, Fukuda N, Nagase H, Fujimura T, Urano T, Homma Y, et
al: Targeting Oct1 genomic function inhibits androgen receptor
signaling and castration-resistant prostate cancer growth.
Oncogene. 35:6350–6358. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang J, Scholtens D, Holko M, Ivancic D,
Lee O, Hu H, Chatterton RT Jr, Sullivan ME, Hansen N, Bethke K, et
al: Lipid metabolism genes in contralateral unaffected breast and
estrogen receptor status of breast cancer. Cancer Prev Res (Phila).
6:321–330. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Marques RB, Dits NF, Erkens-Schulze S, van
Ijcken WF, van Weerden WM and Jenster G: Modulation of androgen
receptor signaling in hormonal therapy-resistant prostate cancer
cell lines. PLoS One. 6:e231442011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jeong HM, Kim RN, Kwon MJ, Oh E, Han J,
Lee SK, Choi JS, Park S, Nam SJ, Gong GY, et al: Targeted exome
sequencing of Korean triple-negative breast cancer reveals
homozygous deletions associated with poor prognosis of adjuvant
chemotherapy-treated patients. Oncotarget. 8:61538–61550. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Su RJ, Jonas BA, Welborn J, Gregg JP and
Chen M: Chronic eosinophilic leukemia, NOS with
t(5;12)(q31;p13)/ETV6-ACSL6 gene fusion: A novel variant of myeloid
proliferative neoplasm with eosinophilia. Hum Pathol (N Y). 5:6–9.
2016.PubMed/NCBI
|
|
37
|
Chen WC, Wang CY, Hung YH, Weng TY, Yen MC
and Lai MD: Systematic analysis of gene expression alterations and
clinical outcomes for long-chain acyl-coenzyme a synthetase family
in cancer. PLoS One. 11:e01556602016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Weedon-Fekjaer MS, Dalen KT, Solaas K,
Staff AC, Duttaroy AK and Nebb HI: Activation of LXR increases
acyl-CoA synthetase activity through direct regulation of ACSL3 in
human placental trophoblast cells. J Lipid Res. 51:1886–1896. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cao A, Li H, Zhou Y, Wu M and Liu J: Long
chain acyl-CoA synthetase-3 is a molecular target for peroxisome
proliferator-activated receptor delta in HepG2 hepatoma cells. J
Biol Chem. 285:16664–16674. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chang YS, Tsai CT, Huangfu CA, Huang WY,
Lei HY, Lin CF, Su IJ, Chang WT, Wu PH, Chen YT, et al: ACSL3 and
GSK-3β are essential for lipid upregulation induced by endoplasmic
reticulum stress in liver cells. J Cell Biochem. 112:881–893. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cui M, Xiao Z, Sun B, Wang Y, Zheng M, Ye
L and Zhang X: Involvement of cholesterol in hepatitis B virus X
protein-induced abnormal lipid metabolism of hepatoma cells via
up-regulating miR-205-targeted ACSL4. Biochem Biophys Res Commun.
445:651–655. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kan CF, Singh AB, Stafforini DM, Azhar S
and Liu J: Arachidonic acid downregulates acyl-CoA synthetase 4
expression by promoting its ubiquitination and proteasomal
degradation. J Lipid Res. 55:1657–1667. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Belkaid A, Ouellette RJ and Surette ME:
17β-estradiol-induced ACSL4 protein expression promotes an invasive
phenotype in estrogen receptor positive mammary carcinoma cells.
Carcinogenesis. 38:402–410. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yao H and Ye J: Long chain acyl-CoA
synthetase 3-mediated phosphatidylcholine synthesis is required for
assembly of very low density lipoproteins in human hepatoma Huh7
cells. J Biol Chem. 283:849–854. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Migita T, Takayama KI, Urano T, Obinata D,
Ikeda K, Soga T, Takahashi S and Inoue S: ACSL3 promotes
intratumoral steroidogenesis in prostate cancer cells. Cancer Sci.
108:2011–2021. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Orlando UD, Garona J, Ripoll GV, Maloberti
PM, Solano ÁR, Avagnina A, Gomez DE, Alonso DF and Podestá EJ: The
functional interaction between acyl-CoA synthetase 4,
5-lipooxygenase and cyclooxygenase-2 controls tumor growth: A novel
therapeutic target. PLoS One. 7:e407942012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Orlando UD, Castillo AF, Dattilo MA,
Solano AR, Maloberti PM and Podesta EJ: Acyl-CoA synthetase-4, a
new regulator of mTOR and a potential therapeutic target for
enhanced estrogen receptor function in receptor-positive and
-negative breast cancer. Oncotarget. 6:42632–42650. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wright HJ, Hou J, Xu B, Cortez M, Potma
EO, Tromberg BJ and Razorenova OV: CDCP1 drives triple-negative
breast cancer metastasis through reduction of lipid-droplet
abundance and stimulation of fatty acid oxidation. Proc Natl Acad
Sci USA. 114:E6556–E6565. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hertz R, Magenheim J, Berman I and
Bar-Tana J: Fatty acyl-CoA thioesters are ligands of hepatic
nuclear factor-4alpha. Nature. 392:512–516. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ning BF, Ding J, Yin C, Zhong W, Wu K,
Zeng X, Yang W, Chen YX, Zhang JP and Zhang X: Hepatocyte nuclear
factor 4 alpha suppresses the development of hepatocellular
carcinoma. Cancer Res. 70:7640–7651. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Maloberti PM, Duarte AB, Orlando UD,
Pasqualini ME, Solano AR, López-Otín C and Podestá EJ: Functional
interaction between acyl-CoA synthetase 4, lipooxygenases and
cyclooxygenase-2 in the aggressive phenotype of breast cancer
cells. PLoS One. 5:e155402010. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Mashima T, Sato S, Okabe S, Miyata S,
Matsuura M, Sugimoto Y, Tsuruo T and Seimiya H: Acyl-CoA synthetase
as a cancer survival factor: Its inhibition enhances the efficacy
of etoposide. Cancer Sci. 100:1556–1562. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Mashima T, Sato S, Sugimoto Y, Tsuruo T
and Seimiya H: Promotion of glioma cell survival by acyl-CoA
synthetase 5 under extracellular acidosis conditions. Oncogene.
28:9–19. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Mashima T, Oh-hara T, Sato S, Mochizuki M,
Sugimoto Y, Yamazaki K, Hamada J, Tada M, Moriuchi T, Ishikawa Y,
Kato Y, et al: p53-defective tumors with a functional
apoptosome-mediated pathway: A new therapeutic target. J Natl
Cancer Inst. 97:765–777. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Schug ZT, Peck B, Jones DT, Zhang Q,
Grosskurth S, Alam IS, Goodwin LM, Smethurst E, Mason S1, Blyth K,
et al: Acetyl-CoA synthetase 2 promotes acetate utilization and
maintains cancer cell growth under metabolic stress. Cancer Cell.
27:57–71. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Cao Y, Pearman AT, Zimmerman GA, McIntyre
TM and Prescott SM: Intracellular unesterified arachidonic acid
signals apoptosis. Proc Natl Acad Sci USA. 97:11280–11285. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Stockwell BR, Friedmann Angeli JP, Bayir
H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gascón S, Hatzios SK and
Kagan VE: Ferroptosis: A regulated cell death nexus linking
metabolism, redox biology, and disease. Cell. 171:273–285. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Yang WS and Stockwell BR: Ferroptosis:
Death by lipid peroxidation. Trends Cell Biol. 26:165–176. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Kagan VE, Mao GW, Qu F, Angeli JP, Doll S,
Croix CS, Dar HH, Liu B, Tyurin VA, Ritov VB, et al: Oxidized
arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem
Biol. 13:81–90. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Doll S, Proneth B, Tyurina YY, Panzilius
E, Kobayashi S, Ingold I, Irmler M, Beckers J, Aichler M, Walch A,
et al: ACSL4 dictates ferroptosis sensitivity by shaping cellular
lipid composition. Nat Chem Biol. 13:91–98. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Yuan H, Li X, Zhang X, Kang R and Tang D:
Identification of ACSL4 as a biomarker and contributor of
ferroptosis. Biochem Biophys Res Commun. 478:1338–1343. 2016.
View Article : Google Scholar : PubMed/NCBI
|
